Rabhi; Cherif

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rabhi; Cherif.The latest application filed is for "compounds for treating neurodegenerative disorders".

Company Profile

0.5.9

Rabhi; Cherif - Bretigny sur Orge FR
Rabhi; Cherif - Les Lilas FR
Rabhi; Cherif - Beaumont FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for obtaining a plant extract and associated compositions Grant 11,129,864 - Rabhi , et al. September 28, 2	2021-09-28
Compounds For Treating Neurodegenerative Disorders App 20210087222 - Rabhi; Cherif ; et al.	2021-03-25
Compounds For Treating Neurodegenerative Disorders App 20210079035 - Rabhi; Cherif ; et al.	2021-03-18
Compounds For Treating Neurodegenerative Disorders App 20210070799 - Rabhi; Cherif ; et al.	2021-03-11
Compositions containing a Withania somnifera extract incubated with a filamentous fungus of the Beauvaria genus Grant 10,596,217 - Rabhi , et al.	2020-03-24
Use of a Withania extract for the treatment of amyloid-related diseases Grant 10,596,216 - Rabhi , et al.	2020-03-24
Method For Obtaining A Plant Extract And Associated Compositions App 20180289761 - Rabhi; Cherif ; et al.	2018-10-11
Method for obtaining a plant extract and associated compositions Grant 9,999,647 - Rabhi , et al. June 19, 2	2018-06-19
Use Of A Withania Extract For The Treatment Of Alpha Synucleinopathies App 20180110820 - Rabhi; Cherif ; et al.	2018-04-26
Use Of A Withania Extract For The Treatment Of Amyloid-related Diseases App 20180042979 - Rabhi; Cherif ; et al.	2018-02-15
Method For Obtaining A Plant Extract And Associated Compositions App 20160101142 - Rabhi; Cherif ; et al.	2016-04-14
3-(4-oxo-4H-chromen-2-yl)-(1H)-quinolin-4-one derivatives, method for preparing same and pharmaceutical compositions containing same Grant 7,339,061 - Brion , et al. March 4, 2	2008-03-04
Medicine comprising a thiourea for use as depigmenting agent or anti-mutagenic and anti-carcinogenic agent App 20060135618 - Jean; Daniel ; et al.	2006-06-22
Novel 3-(4-oxo-4h-chromen-2-yl)-(1H)-quinolin-4-one derivatives, method for preparing same and pharmaceutical compositions containing same App 20060063801 - Brion; Jean-Daniel ; et al.	2006-03-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.